Clinical applications of monoclonal antibody therapy.
Chikako Shimizu, Yasuhiro Matsumura
Abstract
Open-access reader
Chikako Shimizu, Yasuhiro Matsumura
Abstract
Open-access reader
The recent development of humanized monoclonal antibody has made antibody therapy, which has many theoretical attractions, an encouraging choice of treatment in hematology/oncology area. This article reviews the basic theory and clinical applications of major antibody therapy, including Herceptin, Rituxan and other antibodies of interest.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The recent development of humanized monoclonal antibody has made antibody therapy, which has many theoretical attractions, an encouraging choice of treatment in hematology/oncology area. This article reviews the basic theory and clinical applications of major antibody therapy, including Herceptin, Rituxan and other antibodies of interest.
Key concepts: Monoclonal antibody, Antibody therapy, Monoclonal antibody therapy, Medicine, Antibody, Hematology, Oncology, Bispecific antibody